Oxaliplatin, Cas 61825-94-3

Oxaliplatin, Cas 61825-94-3 — platinum-based antineoplastic compound. Manufacturer: MOLEQULE-ON, New Zealand.

• Overview: Oxaliplatin is a platinum coordination complex used clinically as a chemotherapeutic agent (commonly in combination regimens for colorectal cancer). This listing enhances the original product identity for laboratory, analytical, and pharmaceutical development use.
• Chemical / Physical Data: Empirical formula C8H14N2O4Pt; molecular weight ≈ 397.29 g·mol⁻¹.
• Presentation / Size: 100 mg (as supplied).
• Intended use: For research, analytical standard, API sourcing, or formulation development. Not for direct human or veterinary administration unless provided with appropriate regulatory approvals.
• Storage & Handling: Store refrigerated (typically 2–8°C) and protect from light; handle with appropriate PPE and institutional safety procedures. Request lot-specific Certificate of Analysis and Safety Data Sheet prior to use.

Features: direct manufacturer supply from MOLEQULE-ON (New Zealand), suitable for pharmaceutical development and analytical applications; request documentation (COA, SDS, regulatory certificates) for quality and compliance verification.